According to a recent press release, the telemedicine service provider t+ Medicla has linked up with diabetes company Lifescan, one arm of pharmaceutical giant Johnson and Johnson .
Lifescan manufacture and sell blood glucose monitors and test strips for diabetic use. T+ Medical will now be able to use the One Touch Ultra system technology in order to collect blood glucose readings.
T+diabetes, the diabetes-related software created by T+ gathers the data and sends it to a central database. This information is then analysed, and translated for the use of patients. Patients can then view these graphs over either mobile phones or the internet .
The CEO of T+ Medical, Tim Clover, reportedly commented: “This agreement brings together two complementary technologies and offers improved clinical outcomes and services to patients while creating the opportunities for substantial savings for healthcare providers. Lifescan will be able to expand our commercial efforts while still collaborating on developing the product further and investing in clinical trials to quantify the cost and clinical outcomes.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…